Discontinuation report DILANTIN-125 SUSPENSION
| Report ID | 274800 |
| Drug Identification Number | 00023450 |
| Brand name | DILANTIN-125 SUSPENSION |
| Common or Proper name | PHENYTOIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN |
| Strength(s) | 125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 250ML BT |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-12-09 |
| Remaining supply date | 2025-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Discontinued 2025-12-09 - The last Lot Number was: 33129, Expiry Date: 2025-02-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-19 | French | Compare |
| v1 | 2025-12-19 | English | Compare |
Showing 1 to 2 of 2